Noble metals and their compounds have been used as therapeutic agents from the ancient
time in medicine for the treatment of various infections. Recently, much progress has been …

Carbon nanotubes (CNTs), a versatile nanocarrier for doxorubicin (DOX) delivery had
attracted significant attention in drug delivery of pharmaceuticals. Several properties such as …

Background Postoperative progression and chemotherapy resistance is the major cause of
treatment failure in patients with triple-negative breast cancer (TNBC). Currently, there is a …

Nanotechnology is an emerging cutting-edge technology, which involves interdisciplinary
subjects, such as physics, chemistry, biology, material science and medicine. Different …

Background Immune checkpoint blockade (ICB) has been approved for the treatment of
triple-negative breast cancer (TNBC), since it significantly improved the progression-free …

Combining photothermal and chemotherapy is an emerging strategy for tumor irradiation in
a minimally invasive manner, utilizing photothermal transduction agents and anticancer …

Abstracts The phenomenal rise in cancer over the past few years has made it the second
leading cause of death worldwide. Breast cancer constitutes the predominant cancer …

In the current study, the treatment efficacy of ECHCAH was evaluated in vitro studies using
cell viability and flow cytometry in human TNBCs. The results here showed significant …

Regarded as the most invasive subtype, triple-negative breast cancer (TNBC) lacks the
expression of estrogen receptors (ERs), progesterone receptors (PRs), and human …

Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer for which
there is no available targeted therapy. TNBC cases contribute disproportionately to breast …